Drug Patent Expirations for May 28, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. NEXIUM 24HR (esomeprazole magnesium) Astrazeneca Lp Patent number: 5,690,960 Expiration Date: May 25, 2015 NEXIUM (esomeprazole magnesium) Astrazeneca Pharms Patent number: 5,690,960 Expiration Date: May 25, 2015 EGRIFTA […]


Drug Patent Expirations for May 28, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. NEXIUM 24HR (esomeprazole magnesium) Astrazeneca Lp Patent number: 5,690,960 Expiration Date: May 25, 2015 NEXIUM (esomeprazole magnesium) Astrazeneca Pharms Patent number: 5,690,960 Expiration Date: May 25, 2015 ABLAVAR […]


Latest Licensable Biotechnology Inventions

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents below for more details, or visit TechTransferWatch.com for more options. Support for affinity chromatography and method for isolating immunoglobulin Satoshi Nakamura, Tetsuo Fukuta, Yusuke Okano, Tomonori Shiotani, Kouji Tamori, Yu Otani, Shun-Cheng Li, Xing Li, […]


Additional on-line material: Pharmacoeconomics and the growth of the biotechnology industry

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Additional on-line material: Pharmacoeconomics and the growth of the biotechnology industry
Go to paperABSTRACT: Assuming a constant stream of new biotec…


Using Biotechnology, CSI, and Zombies to Promote Science Education in one of America’s Most Challenging Regions

The following paper has been added to the free open access archives at the Journal of Commercial Biotechnology: Using Biotechnology, CSI, and Zombies to Promote Science Education in one of America’s Most Challenging Regions David Eugene Menshew This paper examines the creation of a forensic biotechnology program that engages students, promotes science learning beyond the […]


Drug Patent Expirations for May 21, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ZYVOX (linezolid) Pharmacia And Upjohn Patent number: 5,688,792 Expiration Date: May 18, 2015 SANDOSTATIN LAR (octreotide acetate) Novartis Patent number: 5,688,530 Expiration Date: May 18, 2015 RISPERDAL CONSTA […]


Drug Patent Expirations for May 21, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. SANDOSTATIN LAR (octreotide acetate) Novartis Patent number: 5,688,530 Expiration Date: May 18, 2015 RISPERDAL CONSTA (risperidone) Janssen Pharms Patent number: 5,688,801 Expiration Date: May 18, 2015 ASMANEX TWISTHALER […]


Latest Licensable Biotechnology Inventions

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents below for more details, or visit TechTransferWatch.com for more options. Genotypic tumor progression classifier and predictor Timothy Yeatman, Steven Alan Enkemann, Steven Eschrich, Timothy Yeatman, Steven Alan Enkemann, Steven Eschrich University of South Florida Patent […]


Intellectual property: The driving force for growth and funding

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Intellectual property: The driving force for growth and funding
Go to paperABSTRACT: For most ‘bio-entrepreneurs’ the science is the easy part — levera…


Adventures in Binational Biopharma: Innovative Medicines “Made in India”

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. As a Non-NRI, I did not plan to launch a bio-pharmaceutical start-up company in India on my own. That would be a little crazy. Instead I took a […]